Key terms: With coverage$100/mo (1-mo), $200 (2-mo), $300 (3-mo), $1,300/year cap
However, limited data are available regarding the effects of GLP-1 RAs on albuminuria status and kidney function in real-world settings, including populations with a lower baseline cardiovascular and kidney risk
It is important to emphasize that evidence from these early reports is limited, and the efficacy and safety of FMT for ALS have not yet been established
However, treatment with equimolar doses of GLP1/E markedly improved body weight, food intake, fat mass, leptin levels, glucose metabolism, insulin sensitivity, and circulating insulin levels with far superior efficacy as compared with GLP1 and E monotherapies (Fig
Look for proper concentrations, safe formulations, and reputable brands